Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03693690
Other study ID # 107089-F
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date October 1, 2018
Est. completion date December 31, 2023

Study information

Verified date September 2023
Source Far Eastern Memorial Hospital
Contact Sheng-Mou Hsiao, MD
Phone +89667000
Email smhsiao2@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The main aim of this study is to elucidate factors affecting treatment efficacy of vaginal laser therapy.


Description:

Laser thermotherapy can increase the stiffness of vaginal wall. It has been reported that vaginal laser therapy can be used to treat stress urinary incontinence. However, factor affecting treatment efficacy of vaginal laser therapy remains unknown. Thus the main aim of this study is to elucidate factors affecting treatment efficacy of vaginal laser therapy. Besides, the durability of vaginal laser therapy will be assessed. The above knowledge should be helpful for clinical decision making.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender Female
Age group 20 Years and older
Eligibility Inclusion Criteria: - >20 years old female - had stress urinary incontinence symptoms - Sexual behavior - No urinary tract infection - At their own expense for vaginal laser therapy Exclusion Criteria: - Abnormal vaginal bleeding - Vaginal fistula

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Vaginal laser thermotherapy
Laser thermotherapy can increase the stiffness of vaginal wall. It has been reported that vaginal laser therapy can be used to treat stress urinary incontinence.

Locations

Country Name City State
Taiwan Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital New Taipei Banqiao

Sponsors (1)

Lead Sponsor Collaborator
Far Eastern Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Global response assessment 2 years
Secondary Duration of sustained efficacy Duration of global response assessment = 2 at each visit 2 years